• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘恶化与肺功能下降有关:一项基于人群的纵向研究。

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.

机构信息

London School of Hygiene and Tropical Medicine, London, UK, UK.

UK Severe Asthma Network and National Registry, Queen's University Belfast, Belfast, UK.

出版信息

Thorax. 2023 Jul;78(7):643-652. doi: 10.1136/thorax-2021-217032. Epub 2022 Aug 3.

DOI:10.1136/thorax-2021-217032
PMID:35922128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10313996/
Abstract

RATIONALE

Progressive lung function (LF) decline in patients with asthma contributes to worse outcomes. Asthma exacerbations are thought to contribute to this decline; however, evidence is limited with mixed results.

METHODS

This historical cohort study of a broad asthma patient population in the Optimum Patient Care Research Database, examined asthma patients with 3+eligible post-18th birthday peak expiratory flow rate (PEF) records (primary analysis) or records of forced expiratory flow in 1 s (FEV) (sensitivity analysis). Adjusted linear growth models tested the association between mean annual exacerbation rate (AER) and LF trajectory.

RESULTS

We studied 1 09 182 patients with follow-up ranging from 5 to 50 years, of which 75 280 had data for all variables included in the adjusted analyses. For each additional exacerbation, an estimated additional -1.34 L/min PEF per year (95% CI -1.23 to -1.50) were lost. Patients with AERs >2/year and aged 18-24 years at baseline lost an additional -5.95 L/min PEF/year (95% CI -8.63 to -3.28) compared with those with AER 0. These differences in the rate of LF decline between AER groups became progressively smaller as age at baseline increased. The results using FEV were consistent with the above.

CONCLUSION

To our knowledge, this study is the largest nationwide cohort of its kind and demonstrates that asthma exacerbations are associated with faster LF decline. This was more prominent in younger patients but was evident in older patients when it was related to lower starting LF, suggesting a persistent deteriorating phenotype that develops in adulthood over time. Earlier intervention with appropriate management in younger patients with asthma could be of value to prevent excessive LF decline.

摘要

背景

哮喘患者的肺功能(LF)逐渐下降会导致预后更差。哮喘加重被认为是导致这种下降的原因,但证据有限且结果不一。

方法

本研究通过 Optimum Patient Care Research Database 中的一个广泛的哮喘患者人群的历史队列研究,对 3 岁及以上有合格的呼气峰流速(PEF)记录(主要分析)或 1 秒用力呼气量(FEV)记录的哮喘患者(敏感性分析)进行了研究。调整后的线性增长模型检验了平均每年加重率(AER)与 LF 轨迹之间的关联。

结果

我们研究了 109182 名患者,随访时间从 5 年到 50 年不等,其中 75280 名患者具有纳入调整分析的所有变量的数据。每增加一次加重,预计每年会损失 1.34L/min 的 PEF(95%CI-1.23 至-1.50)。与 AER 为 0 的患者相比,基线年龄为 18-24 岁且 AER >2/年的患者每年会额外损失 5.95L/min 的 PEF(95%CI-8.63 至-3.28)。与 AER 组之间 LF 下降率的这些差异随着基线年龄的增加而逐渐减小。使用 FEV 的结果与上述结果一致。

结论

据我们所知,这是此类研究中规模最大的全国性队列研究,表明哮喘加重与 LF 下降较快有关。在年轻患者中更为明显,但在与较低的起始 LF 相关的老年患者中也很明显,这表明随着时间的推移,一种在成年后逐渐发展的持续恶化的表型。在年轻哮喘患者中尽早进行适当的管理干预可能有助于防止 LF 过度下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/fa7694ee6daf/thorax-2021-217032f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/a3b8afc9a0e6/thorax-2021-217032f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/54ea6f80c37b/thorax-2021-217032f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/ee0295646310/thorax-2021-217032f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/fa7694ee6daf/thorax-2021-217032f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/a3b8afc9a0e6/thorax-2021-217032f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/54ea6f80c37b/thorax-2021-217032f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/ee0295646310/thorax-2021-217032f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270f/10313996/fa7694ee6daf/thorax-2021-217032f04.jpg

相似文献

1
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study.哮喘恶化与肺功能下降有关:一项基于人群的纵向研究。
Thorax. 2023 Jul;78(7):643-652. doi: 10.1136/thorax-2021-217032. Epub 2022 Aug 3.
2
Physical activity and lung function decline in adults with asthma: The HUNT Study.体力活动与哮喘成人肺功能下降:挪威 HUNT 研究。
Respirology. 2017 Feb;22(2):278-283. doi: 10.1111/resp.12884. Epub 2016 Oct 2.
3
Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma.急性加重对肺功能、资源利用及生产力的影响:一项针对未控制哮喘成人的观察性前瞻性研究结果
J Asthma. 2023 Jun;60(6):1072-1079. doi: 10.1080/02770903.2022.2130800. Epub 2022 Oct 20.
4
Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations.哮喘不可逆气流受限的进展:与严重加重的相关性。
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):759-64.e1. doi: 10.1016/j.jaip.2015.05.005. Epub 2015 Jun 6.
5
Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.评估哮喘和慢性支气管炎患者中每周测量呼气峰值流速在监测肺功能年度下降方面的适用性。
Br J Gen Pract. 1996 Jan;46(402):15-8.
6
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.哥本哈根城市心脏研究中哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠患者的长期预后:一项前瞻性基于人群的分析。
Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6.
7
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.COPD 缓解期治疗中加重事件的长期负担与肺功能下降。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 6;15:1909-1918. doi: 10.2147/COPD.S253812. eCollection 2020.
8
Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.从 COPD 队列中观察到哮喘-COPD 重叠患者的肺功能有良好的纵向变化。
Respir Res. 2018 Mar 2;19(1):36. doi: 10.1186/s12931-018-0737-8.
9
Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline.基线时病情得到控制的哮喘患者1秒用力呼气容积随时间的变化
Respir Med. 2014 Jul;108(7):976-82. doi: 10.1016/j.rmed.2014.04.014. Epub 2014 May 10.
10
Severe exacerbations predict excess lung function decline in asthma.严重急性加重预示哮喘患者肺功能会过度下降。
Eur Respir J. 2007 Sep;30(3):452-6. doi: 10.1183/09031936.00165106. Epub 2007 May 30.

引用本文的文献

1
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.2型炎症生物标志物作为重度嗜酸性粒细胞性哮喘生物制剂反应的预测指标
ERJ Open Res. 2025 Aug 26;11(4). doi: 10.1183/23120541.00969-2024. eCollection 2025 Jul.
2
Real-World Effectiveness of Omalizumab Treatment in Adult Asthma Patients.奥马珠单抗治疗成人哮喘患者的真实世界疗效
Yonsei Med J. 2025 Sep;66(9):545-555. doi: 10.3349/ymj.2024.0320.
3
Too Much SAMA, Too Many Exacerbations: A Call for Caution in Asthma.过多的短效抗胆碱能药物,过多的急性加重:哮喘治疗需谨慎呼吁

本文引用的文献

1
Does lung function change in the months after an asthma exacerbation in children?儿童哮喘发作后数月肺功能是否会发生变化?
Pediatr Allergy Immunol. 2021 Aug;32(6):1208-1216. doi: 10.1111/pai.13503. Epub 2021 Mar 29.
2
Potential Severe Asthma Hidden in UK Primary Care.英国初级保健中潜在的严重哮喘。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1612-1623.e9. doi: 10.1016/j.jaip.2020.11.053. Epub 2020 Dec 9.
3
Association between COPD exacerbations and lung function decline during maintenance therapy.COPD 加重与维持治疗期间肺功能下降的关系。
J Clin Med. 2025 Jul 16;14(14):5046. doi: 10.3390/jcm14145046.
4
Predictors of asthma exacerbation between high and low blood eosinophil counts.高、低血嗜酸性粒细胞计数之间哮喘加重的预测因素。
ERJ Open Res. 2025 Jul 7;11(4). doi: 10.1183/23120541.01218-2024. eCollection 2025 Jul.
5
Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling.重度哮喘中的2型基因表达特征与更严重的气道重塑相关。
Clin Transl Allergy. 2025 Jun;15(6):e70060. doi: 10.1002/clt2.70060.
6
Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study.重度哮喘缓解途径:倍利珠单抗治疗的临床疗效及成功的关键预测因素:一项真实世界研究
Biomedicines. 2025 Apr 6;13(4):887. doi: 10.3390/biomedicines13040887.
7
Challenges and Opportunities in Achieving Asthma Remission.实现哮喘缓解的挑战与机遇
J Clin Med. 2025 Apr 20;14(8):2835. doi: 10.3390/jcm14082835.
8
An Updated Systematic Review on Asthma Exacerbation Risk Prediction Models Between 2017 and 2023: Risk of Bias and Applicability.2017年至2023年哮喘急性加重风险预测模型的最新系统评价:偏倚风险和适用性
J Asthma Allergy. 2025 Apr 19;18:579-589. doi: 10.2147/JAA.S509260. eCollection 2025.
9
What is the influence of exacerbations on pulmonary function in pediatric and adolescent patients with severe asthma despite controller therapies?尽管采用了控制治疗,病情加重对重度哮喘儿童和青少年患者的肺功能有何影响?
Clin Transl Allergy. 2025 Apr;15(4):e70046. doi: 10.1002/clt2.70046.
10
Con: clinical remission in asthma - not yet there.反对观点:哮喘的临床缓解——尚未实现。
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0182-2024. Print 2025 Apr.
Thorax. 2020 Sep;75(9):744-753. doi: 10.1136/thoraxjnl-2019-214457. Epub 2020 Jun 12.
4
Association of asthma and smoking with lung function impairment in adolescence and early adulthood: the Isle of Wight Birth Cohort Study.青少年和成年早期哮喘与吸烟和肺功能损害的关联:怀特岛出生队列研究
Eur Respir J. 2020 Mar 5;55(3). doi: 10.1183/13993003.00477-2019. Print 2020 Mar.
5
Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV.峰呼气流量作为哮喘临床试验的终点:与 FEV 的比较。
Respir Res. 2019 Jul 18;20(1):159. doi: 10.1186/s12931-019-1119-6.
6
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.老年人正常肺功能下降率:前瞻性队列研究的系统评价。
BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150.
7
Biological treatments for severe asthma: A major advance in asthma care.生物疗法治疗重度哮喘:哮喘治疗的重大进展。
Allergol Int. 2019 Apr;68(2):158-166. doi: 10.1016/j.alit.2019.01.004. Epub 2019 Feb 18.
8
Role of Biologics in Asthma.生物制剂在哮喘中的作用。
Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445. doi: 10.1164/rccm.201810-1944CI.
9
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.长期口服皮质类固醇治疗对成人严重哮喘的影响及其副作用:对文献中影响数据的重点回顾。
Eur Respir J. 2018 Oct 25;52(4). doi: 10.1183/13993003.00703-2018. Print 2018 Oct.
10
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.儿童时期肺功能轨迹与未来 COPD 风险的预测因素:一项前瞻性队列研究,从生命的第一个十年到第六个十年。
Lancet Respir Med. 2018 Jul;6(7):535-544. doi: 10.1016/S2213-2600(18)30100-0. Epub 2018 Apr 5.